Breast cancer
Conditions
Interventions
10/0
Sponsors
Kurume University School of Medicine Department of Surgery
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1)Patients who have been diagnosed as standard treatment-resistant breast cancer with or without an evaluation lesion. 2)Performance Status: 0-1 (ECOG) 3)The expected survival time longer than 3 months from the entry. 4)Sufficient function of important organs prior to entry: WBC >= 2,500/mm3 lymphocytes>= 1,000/mm3 Hb >= 8.0 g/dL Plt. >= 80,000/mm3 Serum creatinine: <=2 times of the upper limit within normal range in each institute Total bilirubin <=2 times of the upper limit within normal range in each institute 5)Age >= 20 6)Written informed consent to participate
Exclusion criteria
Exclusion criteria: 1)Serious complication including active severe infection, circulatory failure, respiratory failure, renal failure, immunodeficiency, blood coagulation disorder etc. 2)Patients with active double cancer. 3)Patients who had a history of serious allergic disease. 4)(Female) pregnant women, lactating women and patients who want to become pregnant. Male breast cancer patients. 5)Other patients who are identified inappropriate patients for this study by the physicians in charge.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Safety | — |
Secondary
| Measure | Time frame |
|---|---|
| Progression free survival time Tumor specific immune response | — |
Countries
Japan
Contacts
Public ContactToh Uhi
Kurume University School of Medicine Department of Surgery
Outcome results
None listed